{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:19:10Z","timestamp":1787606350787,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chroma.2026.467309","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:12:37Z","timestamp":1785337957000},"page":"467309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures"],"prefix":"10.1016","volume":"1785","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1011-3431","authenticated-orcid":false,"given":"Jonathan","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hemida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-5047","authenticated-orcid":false,"given":"Rodell C.","family":"Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-6391","authenticated-orcid":false,"given":"Erik L.","family":"Regalado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-5823","authenticated-orcid":false,"given":"Davy","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.chroma.2026.467309_bib0001","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41573-024-01041-z","article-title":"Advanced technologies for the development of infectious disease vaccines","volume":"23","author":"Gupta","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.chroma.2026.467309_bib0002","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.chroma.2026.467309_bib0003","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7150\/thno.121775","article-title":"The efficacy of oligonucleotide-based gene therapeutics in gene silencing","volume":"16","author":"Patra","year":"2026","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.chroma.2026.467309_bib0004","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.chroma.2026.467309_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-024-02112-8","article-title":"Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines","volume":"10","author":"Liu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.chroma.2026.467309_bib0006","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.ymthe.2025.05.006","article-title":"The landscape of cell and gene therapy today","volume":"33","author":"Barrett","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.chroma.2026.467309_bib0007","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"6692","key":"10.1016\/j.chroma.2026.467309_bib0008","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4015","article-title":"Modern approaches to therapeutic oligonucleotide manufacturing","volume":"384","author":"Obexer","year":"2024","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.chroma.2026.467309_bib0009","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1021\/acs.jmedchem.6b00551","article-title":"The Medicinal Chemistry of therapeutic oligonucleotides","volume":"59","author":"Wan","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.chroma.2026.467309_bib0010","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.ymthe.2025.02.045","article-title":"Clinical applications of oligonucleotides for cancer therapy","volume":"33","author":"DeFranciscis","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467309_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466308","article-title":"Emerging trends in the characterization of oligonucleotide diastereomers","volume":"1761","author":"Goyon","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465076","article-title":"Two-dimensional sequential selective comprehensive chiralxreversed-phase liquid chromatography of synthetic phosphorothioate oligonucleotide diastereomers","volume":"1730","author":"Li","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"9","key":"10.1016\/j.chroma.2026.467309_bib0013","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1021\/acs.analchem.4c06662","article-title":"Trends in pharmaceutical analysis: the evolving role of liquid chromatography","volume":"97","author":"D'Atri","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2026.345445","article-title":"Therapeutic oligonucleotide (nusinersen) metabolism in cerebrospinal fluid samples of patients with spinal muscular atrophy based on liquid chromatography coupled with mass spectrometry data","volume":"1404","author":"Studzi\u0144ska","year":"2026","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2026.467309_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114928","article-title":"Analysis of therapeutic nucleic acids by capillary electrophoresis","volume":"219","author":"Wei","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"18","key":"10.1016\/j.chroma.2026.467309_bib0016","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/17576180.2025.2565141","article-title":"Recent advances in analytical separation techniques for therapeutic oligonucleotides","volume":"17","author":"Dererova","year":"2025","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2026.467309_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.466865","article-title":"Characterization of siRNA product-related impurities by hydrophilic interaction liquid chromatography (HILIC) coupled with mass spectrometry","volume":"1775","author":"Graglia","year":"2026","journal-title":"J. Chromatogr. A"},{"issue":"29","key":"10.1016\/j.chroma.2026.467309_bib0018","doi-asserted-by":"crossref","first-page":"15717","DOI":"10.1021\/acs.analchem.5c01407","article-title":"Ion-pairing hydrophilic interaction chromatography for impurity profiling of therapeutic phosphorothioated oligonucleotides","volume":"97","author":"Tutis","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpba.2016.12.036","article-title":"Evaluation of size-exclusion chromatography for the analysis of phosphorothioate oligonucleotides","volume":"136","author":"Shimoyama","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2026.467309_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465380","article-title":"Separation and identification of oligonucleotides impurities and degradation products by reversed phase ultra-high performance liquid chromatography using phenyl-bonded stationary phases without ion pairs - a step towards sustainability","volume":"1736","author":"Studzinska","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2026.124922","article-title":"Simple ion-pairing reversed phase LC-UV method for the relative quantification of capping species in mRNA-based modalities","volume":"1271","author":"Maurer","year":"2026","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.chroma.2026.467309_bib0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ab.2009.03.042","article-title":"Reversed-phase ion-pair liquid chromatography analysis and purification of small interfering RNA","volume":"390","author":"McCarthy","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2026.467309_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2023.100079","article-title":"Separation of therapeutic oligonucleotides using ion-pair reversed-phase chromatography based on fundamental separation science","volume":"3","author":"Fornstedt","year":"2023","journal-title":"J. Chromatogr. Open."},{"key":"10.1016\/j.chroma.2026.467309_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117097","article-title":"Characterisation of small RNA-based therapeutics and their process impurities by fast and sensitive liquid chromatography high resolution mass spectrometry","volume":"268","author":"Mill\u00e1n-Mart\u00edn","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2026.467309_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.462860","article-title":"Effect of ion-pairing reagent hydrophobicity on liquid chromatography and mass spectrometry analysis of oligonucleotides","volume":"1666","author":"Donegan","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465915","article-title":"Improving the chromatographic separation of phosphorothioate oligonucleotide from impurities by optimizing selectivity through mobile-phase conditions in ion-pair reversed-phase high-performance liquid chromatography","volume":"1750","author":"Obata","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466147","article-title":"Mechanistic multi-objective optimization of ion-pair reversed-phase liquid chromatography for oligonucleotide purification","volume":"1757","author":"Lesko","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466560","article-title":"pH effects on the separation of oligonucleotides by ion-pair reserved phase liquid chromatography mass spectrometry","volume":"1766","author":"Roussis","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463473","article-title":"Phosphorothioate oligonucleotides separation in ion-pairing reversed-phase liquid chromatography: effect of temperature","volume":"1681","author":"Kadlecova","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465574","article-title":"Evaluation of ion pairing reversed-phase liquid chromatography for the separation of large RNA molecules","volume":"1740","author":"Maurer","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2024.100200","article-title":"Weak to strong ion-pair gradients to expand the selectivity of oligonucleotide separations in reversed phase liquid chromatography - A proof of concept","volume":"7","author":"Fekete","year":"2025","journal-title":"J. Chromatogr. Open."},{"key":"10.1016\/j.chroma.2026.467309_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462269","article-title":"Selectivity limits of and opportunities for ion pair chromatographic separation of oligonucleotides","volume":"1651","author":"Enmark","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466182","article-title":"A universal separation quality factor (SQF) for evaluating liquid chromatographic separations","volume":"1758","author":"Fekete","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.467182","article-title":"Normalized peak distribution uniformity metrics for chromatographic evaluation","volume":"1783","author":"Buff","year":"2026","journal-title":"J. Chromatogr. A"},{"issue":"12","key":"10.1016\/j.chroma.2026.467309_bib0035","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s00216-022-03982-z","article-title":"Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets","volume":"414","author":"Losacco","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465266","article-title":"Automated multicolumn screening workflow in ultra-high pressure hydrophilic interaction chromatography for streamlined method development of polar analytes","volume":"1733","author":"Hemida","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2025.118309","article-title":"Exploring the potential of oligonucleotide mapping with liquid chromatography \u2013 mass spectrometry to study the primary structure of mRNA","volume":"191","author":"Maurer","year":"2025","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.466985","article-title":"A ribonucleic acid mapping brainteaser: solving a ribonuclease 4 \/ribonuclease A crossword using pre- and post-column digestion","volume":"1778","author":"Morreel","year":"2026","journal-title":"J. Chromatogr. A"},{"issue":"13","key":"10.1016\/j.chroma.2026.467309_bib0039","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/acs.analchem.5c08110","article-title":"Automated online direct mRNA sequence mapping using partial RNase T1 digests","volume":"98","author":"Dale","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0040","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/ac960916h","article-title":"Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry","volume":"69","author":"Apffel","year":"1997","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466395","article-title":"Systematic evaluation of phenyl stationary phases for oligonucleotide analysis without ion-pairing reagents","volume":"1762","author":"Tsalmpouris","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467309_bib0042","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00216-019-02236-9","article-title":"Analytical and preparative separation of phosphorothioated oligonucleotides: columns and ion-pair reagents","volume":"412","author":"Enmark","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"issue":"24","key":"10.1016\/j.chroma.2026.467309_bib0043","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1021\/acs.analchem.4c01384","article-title":"Unravelling the link between oligonucleotide structure and diastereomer separation in hydrophilic interaction chromatography","volume":"96","author":"Lardeux","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467309_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114956","article-title":"Separation of phosphorothioate oligonucleotide impurities by WAX HPLC under high organic content elution conditions","volume":"659","author":"Roussis","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2026.467309_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463201","article-title":"Phosphorothioate oligonucleotides separation in ion-pairing reversed-phase liquid chromatography: effect of ion-pairing system","volume":"1676","author":"Kadlecova","year":"2022","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326006370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326006370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:27:07Z","timestamp":1787603227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967326006370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"alternative-id":["S0021967326006370"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467309","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"467309"}}